Literature DB >> 15107519

Cutaneous Aspergillus flavus infection in a neonate.

S Amuchou Singh1, Sourabh Dutta, Anil Narang, Kim Vaiphei.   

Abstract

A premature newborn infant born at 30 weeks gestation developed erythematous papular skin lesions that coalesced to form a necrotic plaque with black eschar. Skin histopathology and culture demonstrated infection with Aspergillus flavus. There was no evidence of Aspergillus flavus infection elsewhere.

Entities:  

Mesh:

Year:  2004        PMID: 15107519     DOI: 10.1007/bf02724105

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  7 in total

1.  Primary cutaneous aspergillosis in ventilated neonates.

Authors:  F C Amod; Y M Coovadia; T Pillay; G Ducasse
Journal:  Pediatr Infect Dis J       Date:  2000-05       Impact factor: 2.129

Review 2.  Invasive aspergillosis in neonates: report of five cases and literature review.

Authors:  J L Rowen; A G Correa; D M Sokol; H K Hawkins; M L Levy; M S Edwards
Journal:  Pediatr Infect Dis J       Date:  1992-07       Impact factor: 2.129

Review 3.  Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

Authors:  D W Denning; D A Stevens
Journal:  Rev Infect Dis       Date:  1990 Nov-Dec

4.  Primary cutaneous aspergillosis--an emerging infection among immunocompromised patients.

Authors:  T J Walsh
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

Review 5.  Primary cutaneous aspergillosis in neonates: case report and review.

Authors:  M Papouli; E Roilides; E Bibashi; A Andreou
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

6.  Primary cutaneous aspergillosis in a premature neonate.

Authors:  R D Granstein; L R First; A J Sober
Journal:  Br J Dermatol       Date:  1980-12       Impact factor: 9.302

Review 7.  Invasive pulmonary aspergillosis in a critically ill neonate: case report and review of invasive aspergillosis during the first 3 months of life.

Authors:  A H Groll; G Jaeger; A Allendorf; G Herrmann; R Schloesser; V von Loewenich
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.